# AI-Driven Ayurvedic Drug Discovery — Complete Phase-Wise Research & Implementation Plan

## Project Title

**AI-Driven Computational Pipeline for Ayurvedic Drug Discovery: Phytochemical Mining, Molecular Docking, and Explainable Binding Prediction**

### Short Title
**AI-Driven Ayurvedic Drug Discovery Pipeline**

---

# 1. Project Overview

This project is a research-oriented computational platform for prioritizing potentially relevant Ayurvedic phytochemicals against selected therapeutic targets.

The system integrates:

- Ayurvedic medicinal-plant and phytochemical data
- Public chemical databases
- Protein/target structural data
- Cheminformatics
- Molecular docking
- Machine learning
- Explainable AI
- Scientific literature retrieval and RAG
- Agentic AI workflows
- Interactive molecular visualization

The system is intended for **computational candidate prioritization**, not experimental or clinical validation.

---

# 2. Overall Research Strategy

The project will be developed in the following sequence:

1. Literature Review & Research Design
2. Data Collection, Segregation & Cleaning
3. Dataset Construction, Training & Benchmarking
4. Scientific Pipeline Implementation
5. Evaluation Metrics & Validation
6. Results & Scientific Analysis
7. Discussion, Limitations & Future Work
8. Final Report, Presentation & Demonstration

The project should be developed phase-by-phase rather than attempting to build the complete application in one step.

---

# 3. PHASE 1 — Literature Review & Research Design

## Goal

Establish the scientific foundation of the project, identify the research gap, and define a reproducible methodology before implementation.

## 3.1 Literature Review Areas

### A. Computational Ayurvedic Drug Discovery

Review:

- Ayurvedic medicinal plants
- Phytochemicals
- Traditional medicine databases
- Network pharmacology
- In-silico drug discovery
- Target identification
- Molecular docking
- ADMET/drug-likeness
- Computational prioritization

### B. Phytochemical Databases

Study:

- IMPPAT
- TCMSP
- TCMID
- PubChem
- Other relevant natural-product databases where justified

**Important:** TCMSP and TCMID are complementary traditional-medicine resources and should not be described as exclusively Ayurvedic databases.

### C. Molecular Docking

Review:

- Protein–ligand docking
- Binding affinity/scoring
- Docking poses
- Binding sites
- Hydrogen bonds
- Hydrophobic interactions
- Key residues
- AutoDock Vina
- Docking limitations
- Docking validation

### D. AI/ML in Drug Discovery

Review:

- Molecular descriptors
- Molecular fingerprints
- QSAR
- Random Forest
- XGBoost
- SVM
- Neural/deep learning where justified
- Binding-affinity prediction
- Dataset splitting
- Data leakage
- Generalization

### E. Explainable AI

Review:

- SHAP
- Feature importance
- Local explanations
- Global explanations
- Limitations of interpretability

### F. Literature RAG and LLMs

Review:

- Scientific information retrieval
- Embeddings
- Semantic search
- Retrieval-Augmented Generation
- Evidence extraction
- Citation grounding
- Hallucination/reliability

### G. Agentic AI

Review:

- AI agents
- Tool calling
- Multi-step scientific workflows
- Agent orchestration
- Validation agents
- Failure handling

---

## 3.2 Literature Matrix

Create a structured literature-review table:

| Paper | Year | Topic | Dataset | Method | Main Result | Limitation | Relevance |
|---|---|---|---|---|---|---|---|

Target approximately **15–25 strong papers initially**, then expand where necessary.

---

## 3.3 Research Gap

The review should identify the gap between:

> Ayurvedic phytochemical research + molecular docking + ML-based prediction + explainable AI + scientific literature mining + agentic workflow automation.

The final research gap must be based on the actual literature rather than being invented before reviewing the papers.

---

## 3.4 Research Questions

Possible research questions:

1. Can Ayurvedic phytochemicals be computationally prioritized against a defined therapeutic target?
2. How effectively can molecular descriptors and fingerprints support binding-related ML prediction?
3. How do ML predictions compare with molecular docking results?
4. Can SHAP provide interpretable explanations for model predictions?
5. Can literature retrieval provide independent evidence for computationally prioritized candidates?
6. Can an agentic workflow reliably orchestrate the computational drug-discovery pipeline?

These questions should be finalized after the literature review.

---

## 3.5 Phase 1 Deliverables

- Literature matrix
- Research background
- Research gap
- Research objectives
- Research questions
- Hypotheses, if appropriate
- Target disease/therapeutic area
- Target protein(s)
- Proposed methodology
- Initial system architecture
- Evaluation plan

---

# 4. PHASE 2 — DATA COLLECTION, SEGREGATION & CLEANING

## Goal

Convert heterogeneous public resources into a clean, reproducible master dataset.

---

## 4.1 Primary Data Sources

### IMPPAT

Use for:

- Ayurvedic medicinal plants
- Phytochemicals
- Plant–compound relationships
- Traditional therapeutic information

### PubChem

Use for:

- Compound identifiers
- Canonical/isomeric SMILES
- Molecular formula
- Molecular weight
- Chemical structures
- 2D/3D information where available

### TCMSP

Use as a complementary traditional-medicine resource for:

- Compounds
- Targets
- Pharmacological information

### TCMID

Use as a complementary traditional-medicine resource for:

- Traditional-medicine compounds
- Herbs
- Targets
- Associations

### RCSB PDB

Use for:

- Protein structures
- PDB identifiers
- Structural information

### PubMed / Europe PMC

Use for:

- Scientific literature
- Compound–target evidence
- Disease relationships
- Supporting publications

---

# 5. Data Segregation

Create separate logical datasets.

## 5.1 Compound Dataset

Suggested fields:

- Compound ID
- Compound name
- Plant/source
- Source database
- PubChem CID
- SMILES
- Molecular formula
- Molecular weight
- Chemical class
- Therapeutic information

---

## 5.2 Target Dataset

Suggested fields:

- Target ID
- Protein name
- Gene/protein identifier
- Target description
- Disease association
- PDB ID
- Structural information

---

## 5.3 Literature Dataset

Suggested fields:

- PMID
- DOI
- Title
- Abstract
- Publication year
- Compound
- Target
- Disease
- Evidence type
- Source

---

## 5.4 Docking Dataset

Suggested fields:

- Compound ID
- Target ID
- PDB ID
- Docking score
- Pose ID
- Binding-site information
- Hydrogen bonds
- Hydrophobic interactions
- Key residues
- Interaction features

---

# 6. Data Cleaning

Perform:

- Duplicate removal
- Missing-value analysis
- SMILES validation
- Structure normalization
- Invalid molecule removal
- Identifier mapping
- Cross-database entity resolution
- Unit standardization
- Metadata normalization

Maintain provenance for every important record.

---

# 7. Master Dataset

The final integrated structure should conceptually be:

```text
Plants
   ↓
Phytochemicals
   ↓
Chemical Structures
   ↓
Targets
   ↓
Protein Structures
   ↓
Docking Results
   ↓
Interaction Features
   ↓
ML Features
   ↓
Literature Evidence
```

Deliverable:

**Clean, versioned, reproducible master dataset**

---

# 8. PHASE 3 — DATASET TRAINING & BENCHMARKING

## Goal

Determine which computational model and feature representation performs best before integrating the model into the final application.

---

# 9. Feature Engineering

Use RDKit to calculate:

### Molecular descriptors

Examples:

- Molecular weight
- LogP
- Hydrogen-bond donors
- Hydrogen-bond acceptors
- Rotatable bonds
- Topological descriptors
- Polar surface area
- Other justified physicochemical descriptors

### Molecular fingerprints

Use:

- Morgan fingerprints

Additional fingerprints can be evaluated if scientifically justified.

---

# 10. Dataset Splitting

Create:

- Training set
- Validation set
- Independent test set

For molecular datasets, evaluate **scaffold-based splitting** rather than relying only on random splitting.

The exact split strategy should be documented.

---

# 11. Candidate Models

Benchmark appropriate models such as:

- Baseline model
- Random Forest
- XGBoost
- Support Vector Machine
- Neural network/deep learning model if justified by dataset size and research design

Do not include complex models merely for the sake of using deep learning.

---

# 12. Benchmarking

Compare models using the same preprocessing and evaluation framework.

Example:

| Model | MAE | RMSE | R² | Pearson | Spearman |
|---|---:|---:|---:|---:|---:|
| Baseline | — | — | — | — | — |
| Random Forest | — | — | — | — | — |
| XGBoost | — | — | — | — | — |
| SVM | — | — | — | — | — |
| Neural Network | — | — | — | — | — |

Actual values must come from experiments.

---

# 13. Data Leakage Prevention

Explicitly check for:

- Duplicate compounds across splits
- Near-identical molecules
- Scaffold overlap
- Target leakage
- Literature-derived leakage
- Duplicate docking records
- Features generated using information unavailable at prediction time

This is a critical scientific requirement.

---

# 14. Phase 3 Deliverables

- Versioned training dataset
- Feature-generation pipeline
- Train/validation/test splits
- Benchmark experiments
- Model comparison
- Best model
- Saved model artifact
- Reproducible training code
- Experiment logs

---

# 15. PHASE 4 — FULL SCIENTIFIC IMPLEMENTATION

Only after the research design and benchmarking should the complete application be implemented.

---

# 16. Scientific Pipeline

```text
Therapeutic Question
        ↓
Literature Review
        ↓
Target Selection
        ↓
Ayurvedic Plant Selection
        ↓
Phytochemical Retrieval
        ↓
IMPPAT / TCMSP / TCMID
        ↓
PubChem Structure Retrieval
        ↓
Data Cleaning
        ↓
RDKit Descriptors + Morgan Fingerprints
        ↓
Candidate Filtering
        ↓
Target / Protein Selection
        ↓
RCSB PDB
        ↓
Protein Preparation
        ↓
Ligand Preparation
        ↓
Binding-Site Definition
        ↓
AutoDock Vina
        ↓
Docking Scores + Poses
        ↓
PLIP Interaction Analysis
        ↓
ML Prediction
        ↓
SHAP Explainability
        ↓
PubMed / Literature Retrieval
        ↓
RAG Evidence Synthesis
        ↓
Agentic Validation
        ↓
Candidate Prioritization
        ↓
3D Visualization
        ↓
Final Computational Report
```

---

# 17. 4.1 Cheminformatics Pipeline

Use:

- RDKit
- Open Babel where necessary

Process:

```text
SMILES
 ↓
Validation
 ↓
Standardization
 ↓
Molecular Structure
 ↓
Descriptors
 ↓
Morgan Fingerprint
 ↓
Feature Matrix
```

---

# 18. 4.2 Protein Pipeline

Use RCSB PDB structures.

Process:

```text
Target
 ↓
PDB Structure Retrieval
 ↓
Structure Quality Check
 ↓
Chain Selection
 ↓
Water/cofactor handling where appropriate
 ↓
Protein Preparation
 ↓
Docking-Ready Protein
```

All preparation decisions should be documented.

---

# 19. 4.3 Ligand Pipeline

```text
Compound
 ↓
SMILES
 ↓
Structure Validation
 ↓
3D Conformation
 ↓
Geometry Preparation
 ↓
Charge/atom-type preparation as required
 ↓
PDBQT
```

Use Meeko where appropriate for AutoDock Vina preparation.

---

# 20. 4.4 Molecular Docking

Primary docking engine:

**AutoDock Vina**

Workflow:

```text
Prepared Protein
       +
Prepared Ligand
       ↓
Binding-Site Configuration
       ↓
AutoDock Vina
       ↓
Docking Poses
       ↓
Docking Scores
       ↓
Pose Ranking
```

---

# 21. 4.5 Interaction Analysis

Use **PLIP** to identify:

- Hydrogen bonds
- Hydrophobic interactions
- Salt bridges
- π interactions
- Key interacting residues
- Protein–ligand interaction patterns

Docking scores should not be treated as the only evidence of binding quality.

---

# 22. 4.6 Machine Learning

The selected benchmark model is integrated into the application.

Input:

```text
Molecular Descriptors
+
Morgan Fingerprints
+
Other validated features
```

Output:

```text
Predicted Binding-Related Value
+
Uncertainty/Confidence where scientifically supported
```

---

# 23. 4.7 Explainable AI

Use **SHAP**.

Provide:

### Global explanation

Which features generally influence model predictions?

### Local explanation

Why did the model give this prediction for a particular compound?

Possible outputs:

- SHAP feature importance
- Feature contribution plots
- Compound-level explanation
- Positive/negative feature contributions

---

# 24. 4.8 Literature Retrieval + RAG

Pipeline:

```text
Compound / Target
       ↓
PubMed / Europe PMC
       ↓
Relevant Publications
       ↓
Text Processing
       ↓
Embeddings
       ↓
Vector Search
       ↓
Relevant Evidence
       ↓
LLM Synthesis
       ↓
Citation-Grounded Report
```

The system should clearly distinguish:

- Published evidence
- Computational prediction
- Model inference
- System-generated interpretation

---

# 25. 4.9 Agentic AI Workflow

Use **LangGraph** for orchestration.

## Literature Agent

Responsibilities:

- Search scientific literature
- Retrieve evidence
- Identify known compound–target relationships
- Summarize relevant findings

## Compound Agent

Responsibilities:

- Search compound sources
- Retrieve identifiers
- Retrieve structures
- Validate chemical information

## Target Agent

Responsibilities:

- Identify target information
- Retrieve PDB structures
- Check structural suitability

## Molecular Preparation Agent

Responsibilities:

- Prepare ligand
- Prepare protein
- Generate docking-ready inputs

## Docking Agent

Responsibilities:

- Configure docking
- Run AutoDock Vina
- Store scores
- Store poses

## Interaction Agent

Responsibilities:

- Run PLIP
- Extract interactions
- Summarize key residues

## ML Agent

Responsibilities:

- Generate features
- Load trained model
- Generate predictions
- Track model version

## XAI Agent

Responsibilities:

- Generate SHAP explanations
- Explain predictions

## Validation Agent

Responsibilities:

- Compare docking and ML
- Cross-check literature
- Detect missing evidence
- Flag contradictions
- Flag low-confidence conclusions

## Report Agent

Responsibilities:

- Combine validated results
- Generate structured reports
- Separate evidence from predictions

---

# 26. Agentic Architecture

```text
                 ┌──────────────────┐
                 │   User / Query   │
                 └────────┬─────────┘
                          ↓
                 ┌──────────────────┐
                 │ LangGraph        │
                 │ Orchestrator     │
                 └────────┬─────────┘
                          ↓
       ┌─────────────────────────────────────┐
       │                                     │
       ↓                                     ↓
Literature Agent                       Compound Agent
       ↓                                     ↓
Target Agent                          Preparation Agent
       ↓                                     ↓
Docking Agent                         Interaction Agent
       └───────────────┬─────────────────────┘
                       ↓
                   ML Agent
                       ↓
                   XAI Agent
                       ↓
               Validation Agent
                       ↓
                 Report Agent
                       ↓
                 Final Ranking
```

Agents should use deterministic tools wherever possible. LLMs should not replace validated scientific calculations.

---

# 27. 4.10 Candidate Ranking

Candidate prioritization should use scientifically justified criteria such as:

- Docking score
- ML-predicted value
- Prediction uncertainty/confidence
- Molecular properties
- Protein–ligand interaction quality
- Literature support
- Data quality
- Reproducibility/consistency

Do not introduce arbitrary weights without justification.

A candidate should be presented as a:

> **Computationally prioritized hit**

rather than a proven drug.

---

# 28. 4.11 Frontend

Do **not** use Streamlit.

Use:

- React.js
- TypeScript
- Tailwind CSS
- Plotly.js
- 3Dmol.js

---

# 29. Frontend Pages

## Home

- Project overview
- Search
- Pipeline status
- Key statistics

## Compound Search

- Search by compound
- Plant
- Target
- Database

## Compound Profile

- Structure
- SMILES
- Properties
- Source
- Associated targets
- Literature

## Target Page

- Protein information
- PDB structures
- Associated compounds
- Docking results

## Docking Workspace

- Select protein
- Select ligand
- Configure docking
- Start workflow

## Docking Results

- Docking score
- Pose information
- Interactions
- Ranked candidates

## 3D Viewer

Use 3Dmol.js for:

- Protein
- Ligand
- Binding pocket
- Interacting residues
- Docking pose

## AI Prediction

Display:

- Model prediction
- Model used
- Feature information
- Uncertainty where supported

## Explainable AI

Display:

- SHAP plots
- Feature contributions
- Compound-level explanation

## Literature

Display:

- Retrieved papers
- Evidence
- Citations
- RAG-generated synthesis

## Candidate Ranking

Display:

- Ranked candidates
- Evidence
- Docking
- ML
- Literature
- Interaction data

## Final Report

Generate a structured computational report.

---

# 30. Backend

Use:

- Python
- FastAPI
- Pydantic
- SQLAlchemy
- PostgreSQL

The backend should expose REST APIs for:

- Compound search
- Target search
- Dataset access
- Docking jobs
- Docking results
- ML prediction
- SHAP explanation
- Literature retrieval
- Candidate ranking
- Report generation

---

# 31. PHASE 5 — EVALUATION METRICS & VALIDATION

This phase should be planned independently from implementation.

---

# 32. ML Metrics

For regression:

- MAE
- RMSE
- R²
- Pearson correlation
- Spearman correlation

For classification, if classification is introduced:

- Accuracy
- Precision
- Recall
- F1-score
- ROC-AUC
- PR-AUC

Use only metrics appropriate to the actual prediction task.

---

# 33. Docking Evaluation

Evaluate:

- Docking score
- Pose consistency
- Interaction quality
- Hydrogen bonds
- Hydrophobic interactions
- Key-residue interactions
- Reproducibility where applicable

Where appropriate, include a recognized docking validation strategy rather than relying only on raw scores.

---

# 34. Literature/RAG Evaluation

Evaluate:

- Retrieval relevance
- Evidence coverage
- Citation correctness
- Groundedness
- Hallucination rate
- Answer faithfulness

---

# 35. Agent Evaluation

Measure:

- Task completion rate
- Tool-call correctness
- Workflow success
- Validation accuracy
- Failure recovery
- Reproducibility

---

# 36. End-to-End Scientific Validation

Compare:

```text
ML Prediction
      ↕
Docking
      ↕
Protein-Ligand Interactions
      ↕
Published Literature
```

Classify findings as:

- Strongly supported
- Partially supported
- Computationally predicted
- Conflicting evidence
- Insufficient evidence

---

# 37. PHASE 6 — RESULTS & SCIENTIFIC ANALYSIS

## 37.1 Dataset Results

Report:

- Number of plants
- Number of compounds
- Number of targets
- Number of structures
- Number of literature records
- Number of cleaned records
- Number of excluded records
- Reasons for exclusion

---

# 38. 37.2 Benchmark Results

Example format:

| Model | MAE | RMSE | R² | Pearson | Spearman |
|---|---:|---:|---:|---:|---:|
| Baseline | — | — | — | — | — |
| Random Forest | — | — | — | — | — |
| XGBoost | — | — | — | — | — |
| SVM | — | — | — | — | — |

Do not fabricate values. Populate only from actual experiments.

---

# 39. Docking Results

Report:

- Top compounds
- Target proteins
- Docking scores
- Binding poses
- Key residues
- Interaction types
- Structural visualizations

---

# 40. ML Results

Report:

- Predictions
- Model performance
- Confidence/uncertainty where available
- Comparison with docking
- Generalization performance

---

# 41. XAI Results

Report:

- Important molecular features
- SHAP global importance
- SHAP local explanations
- Relationship between features and predictions

---

# 42. Literature Results

For top candidates, report:

- Existing literature
- Known target relationships
- Disease relevance
- Supporting evidence
- Contradictory evidence
- Evidence strength

---

# 43. Final Candidate Ranking

A final candidate table can contain:

| Rank | Compound | Plant | Target | Docking | ML Prediction | Interactions | Literature | Evidence Level |
|---:|---|---|---|---:|---:|---|---|---|

The ranking methodology must be documented and reproducible.

---

# 44. PHASE 7 — DISCUSSION, LIMITATIONS & FUTURE WORK

## Discussion

Explain:

- Why top candidates ranked highly
- Agreement between docking and ML
- Literature support
- Important molecular features
- Unexpected findings
- Scientific interpretation

---

# 45. Limitations

Explicitly discuss:

### Dataset limitations

- Missing compounds
- Database coverage
- Metadata inconsistencies
- Dataset bias

### Docking limitations

- Scoring-function limitations
- Protein flexibility
- Solvent effects
- Conformational limitations
- Docking score interpretation

### ML limitations

- Dataset size
- Distribution shift
- Scaffold generalization
- Feature limitations
- Uncertainty

### RAG/LLM limitations

- Retrieval errors
- Incomplete literature
- Hallucinations
- Citation errors

### Agent limitations

- Tool-call failures
- Workflow errors
- Incorrect intermediate decisions
- Need for deterministic validation

### Scientific limitation

Computational evidence does not establish experimental efficacy, safety, pharmacokinetics, or clinical effectiveness.

---

# 46. Future Work

Potential extensions:

- Molecular dynamics
- Free-energy calculations
- ADMET prediction
- Larger benchmark datasets
- More protein targets
- Experimental validation
- Human pharmacology integration
- Multi-modal molecular models
- Improved uncertainty estimation
- Automated reproducibility tracking

Only include extensions that are realistically appropriate for the project scope.

---

# 47. PHASE 8 — FINAL REPORT & PRESENTATION

## Presentation Structure

### Slide 1
Title

### Slide 2
Problem Statement

### Slide 3
Motivation

### Slide 4
Background

### Slide 5
Literature Review

### Slide 6
Research Gap

### Slide 7
Objectives

### Slide 8
Research Questions

### Slide 9
Dataset

### Slide 10
Data Preprocessing

### Slide 11
Scientific Pipeline

### Slide 12
ML Methodology

### Slide 13
Molecular Docking

### Slide 14
RAG + Agentic Architecture

### Slide 15
System Architecture

### Slide 16
Evaluation Metrics

### Slide 17
Benchmark Results

### Slide 18
Docking Results

### Slide 19
ML Results

### Slide 20
SHAP/XAI Results

### Slide 21
Literature Validation

### Slide 22
Final Candidate Ranking

### Slide 23
Limitations

### Slide 24
Future Work

### Slide 25
Conclusion

---

# 48. Live Demonstration

Recommended demonstration flow:

```text
Select Disease / Target
        ↓
Retrieve Ayurvedic Compounds
        ↓
Clean + Validate
        ↓
Filter Candidates
        ↓
Prepare Protein + Ligands
        ↓
Run Docking
        ↓
Analyze Interactions
        ↓
Run ML Prediction
        ↓
Generate SHAP Explanation
        ↓
Retrieve Scientific Literature
        ↓
Agentic Validation
        ↓
Rank Candidates
        ↓
Show 3D Molecular Interaction
        ↓
Generate Final Report
```

---

# 49. COMPLETE TECHNOLOGY STACK

## Programming

- Python 3.11
- TypeScript
- JavaScript

## Frontend

- React.js
- TypeScript
- Tailwind CSS
- Plotly.js
- 3Dmol.js

## Backend

- FastAPI
- Pydantic

## Database

- PostgreSQL
- SQLAlchemy

## Data Science

- Pandas
- NumPy
- SciPy

## Cheminformatics

- RDKit
- Open Babel

## Docking

- AutoDock Vina
- Meeko
- PLIP

## Machine Learning

- Scikit-learn
- XGBoost
- PyTorch, only if justified

## Explainable AI

- SHAP

## Literature / RAG

- PubMed
- Europe PMC where appropriate
- Sentence Transformers
- FAISS or Chroma
- LLM

## Agentic AI

- LangGraph

## Testing

- Pytest
- Vitest
- React Testing Library

## Code Quality

- Ruff
- Black
- MyPy
- pre-commit

## Infrastructure

- Docker
- Docker Compose
- Git
- GitHub
- Conda/Micromamba

## Optional Infrastructure

- Redis
- Celery

Use Redis/Celery only if long-running jobs require asynchronous execution.

---

# 50. System Architecture

```text
                         USER
                          │
                          ▼
                 ┌─────────────────┐
                 │ React Frontend  │
                 │ TypeScript      │
                 │ Tailwind        │
                 └────────┬────────┘
                          │ REST API
                          ▼
                 ┌─────────────────┐
                 │ FastAPI Backend │
                 └────────┬────────┘
                          │
          ┌───────────────┼────────────────┐
          │               │                │
          ▼               ▼                ▼
    PostgreSQL      Scientific Engine   Agent Layer
          │               │                │
          │       ┌───────┼────────┐       │
          │       │       │        │       │
          │      RDKit  Vina      PLIP  LangGraph
          │       │       │        │       │
          │       └───────┼────────┘       │
          │               │                │
          │               ▼                │
          │              ML/XAI            │
          │               │                │
          │               ▼                │
          │            SHAP                │
          │                                │
          └───────────────┬────────────────┘
                          ▼
                   Literature/RAG
                          │
                          ▼
                  Validation + Report
                          │
                          ▼
                  Candidate Ranking
                          │
                          ▼
                    3D Visualization
```

---

# 51. Suggested Repository Structure

```text
ayurvedic-drug-discovery/
│
├── frontend/
│   └── src/
│       ├── components/
│       ├── pages/
│       ├── services/
│       ├── types/
│       └── app/
│
├── backend/
│   └── app/
│       ├── api/
│       ├── models/
│       ├── schemas/
│       ├── services/
│       └── main.py
│
├── data/
│   ├── raw/
│   ├── processed/
│   └── metadata/
│
├── cheminformatics/
│   ├── smiles/
│   ├── descriptors/
│   ├── fingerprints/
│   └── structures/
│
├── docking/
│   ├── proteins/
│   ├── ligands/
│   ├── configs/
│   ├── results/
│   └── analysis/
│
├── ml/
│   ├── preprocessing/
│   ├── features/
│   ├── training/
│   ├── evaluation/
│   └── models/
│
├── xai/
│   └── shap/
│
├── literature/
│   ├── retrieval/
│   ├── processing/
│   ├── embeddings/
│   └── rag/
│
├── agents/
│   ├── literature_agent/
│   ├── compound_agent/
│   ├── target_agent/
│   ├── docking_agent/
│   ├── ml_agent/
│   ├── xai_agent/
│   ├── validation_agent/
│   └── report_agent/
│
├── notebooks/
├── tests/
├── docs/
├── scripts/
├── docker/
│
├── docker-compose.yml
├── requirements.txt
├── environment.yml
├── README.md
└── LICENSE
```

---

# 52. AI-Assisted Development Strategy

The user already has **Claude Pro**.

Use Claude Pro/Claude Code primarily for:

- Repository creation
- Code implementation
- Refactoring
- Debugging
- Test creation
- Docker setup
- Frontend/backend integration
- Scientific pipeline implementation

Use a second AI/reviewer, such as ChatGPT, for:

- Scientific methodology review
- Literature-review planning
- Architecture critique
- ML methodology review
- Data leakage checks
- Experimental-design review
- Interpretation of results
- Presentation and report preparation

---

# 53. Recommended Claude Development Sequence

Do not give Claude one giant instruction such as:

> “Build the entire project.”

Instead:

```text
Phase 1
Research Design
        ↓
Phase 2
Data Pipeline
        ↓
Phase 3
Benchmarking
        ↓
Phase 4
Cheminformatics
        ↓
Phase 5
Docking
        ↓
Phase 6
ML + XAI
        ↓
Phase 7
Literature RAG
        ↓
Phase 8
Agentic Workflow
        ↓
Phase 9
FastAPI
        ↓
Phase 10
React Frontend
        ↓
Phase 11
Integration
        ↓
Phase 12
Testing
        ↓
Phase 13
Docker
        ↓
Phase 14
Scientific Validation
```

At every phase:

1. Implement
2. Run tests
3. Inspect outputs
4. Validate scientifically
5. Document decisions
6. Commit to Git
7. Move to the next phase

---

# 54. Definition of Done

The project should not be considered complete merely because the frontend works.

A research-ready version should have:

- Reproducible dataset pipeline
- Documented data provenance
- Validated molecular structures
- Reproducible feature generation
- Leakage-aware dataset splitting
- Benchmark comparison
- Reproducible docking workflow
- Interaction analysis
- Validated ML model
- Explainability
- Literature evidence retrieval
- Agent validation
- End-to-end evaluation
- Reproducible experiments
- Automated tests
- Documentation
- Dockerized deployment
- Scientific limitations
- Final results
- Presentation
- Final report

---

# 55. Final End-to-End Research Workflow

```text
                    RESEARCH QUESTION
                           ↓
                  LITERATURE REVIEW
                           ↓
                    RESEARCH GAP
                           ↓
              OBJECTIVES + METHODOLOGY
                           ↓
                    DATA COLLECTION
                           ↓
                DATA SEGREGATION
                           ↓
                    DATA CLEANING
                           ↓
                  MASTER DATASET
                           ↓
                 FEATURE ENGINEERING
                           ↓
               TRAIN/VAL/TEST SPLIT
                           ↓
              MODEL TRAINING
                           ↓
               MODEL BENCHMARKING
                           ↓
                 BEST MODEL
                           ↓
              SCIENTIFIC IMPLEMENTATION
                           ↓
               MOLECULAR DOCKING
                           ↓
             INTERACTION ANALYSIS
                           ↓
                  ML PREDICTION
                           ↓
                       SHAP
                           ↓
                  LITERATURE RAG
                           ↓
                 AGENTIC VALIDATION
                           ↓
                CANDIDATE RANKING
                           ↓
                  EVALUATION METRICS
                           ↓
               SCIENTIFIC VALIDATION
                           ↓
                       RESULTS
                           ↓
                     DISCUSSION
                           ↓
                    LIMITATIONS
                           ↓
                   FUTURE WORK
                           ↓
                 FINAL REPORT
                           ↓
                  PRESENTATION
                           ↓
                  LIVE DEMO
```

---

# 56. Core Scientific Principle

The final system should never imply:

> “The AI discovered a drug.”

Instead, the scientifically appropriate conclusion is:

> **“The integrated computational pipeline prioritizes Ayurvedic phytochemical candidates based on molecular, docking, machine-learning, interaction, and literature-derived evidence, providing hypotheses for subsequent experimental validation.”**

This distinction is essential for a credible academic/research project.

---

# 57. Final Project Outcome

The final product should be both:

### A. A Research Study

with:

- Literature review
- Research gap
- Dataset
- Methodology
- Benchmarking
- Metrics
- Results
- Discussion
- Limitations
- Future work

### B. A Working Scientific Software Platform

with:

- React interface
- FastAPI backend
- PostgreSQL database
- Cheminformatics pipeline
- Molecular docking
- ML prediction
- SHAP explainability
- Literature RAG
- LangGraph agents
- Candidate ranking
- 3D molecular visualization
- Automated report generation

Therefore, the project should be developed as a **scientific computational research platform**, not simply as an AI-powered web application.
